Policy News
Unblocking Multinational Clinical Trials in Europe: Progress, but More to Do
In March 2026, the European Commission published updated guidance on the Clinical Trials Regulation, introducing practical changes to improve how c...
From Plans to Patients: Are EU Cancer Screening and NCD Policies Delivering?
Are EU cancer screening and prevention policies truly reaching patients? We assess the progress of Europe’s Beating Cancer Plan and the SANT Comm...
Connecting the Dots: Obesity, Digestive Diseases and Cancers – A Call for Integrated Prevention and Policy Action
DiCE joined EU policymakers and health experts on 5 June to address obesity’s role in digestive diseases and cancers. The event called for coordi...
Spotlight on Early-Onset Digestive Cancers: DiCE Hosts High-Level Policy Meeting at the European Parliament
Riding on the momentum of ENTERO2024, DiCE spotlighted early-onset digestive cancers at the European Parliament, uniting MEPs, experts, and patient...
Ensuring Access to Critical Medicines: What Digestive Cancer Patients Need from the Critical Medicines Act
The European Commission’s proposal for a Critical Medicines Act marks a significant step toward securing the supply, availability, and accessib...
United Against Cancer: Driving Policy and Advocacy at the European Cancer Summit 2024
This event explored innovative strategies to address inequalities and advance cancer care across Europe, aligning closely with Digestive Cancers Eu...
Appeal to President von der Leyen to Appoint a Vice-President for Health, Wellbeing, and Social Rights
DiCE and 30 organisations brought together by the EU4Health Civil Society Alliance have published a letter to European Commission President nominee...
Von der Leyen’s Reelection Could Mean Continuity, Yet Shifts in Health Priorities May Impact Cancer Funding
Ursula von der Leyen has been re-elected as President of the European Commission, signaling a potential shift in political priorities away from hea...
Do You Want to Have a Say in which Treatments Will Be Available in EU Countries? Get involved in EU HTA
HTA Regulation will involve patients in joint technology assessments at the EU level for oncology treatments. This will utilise patients’ kno...
Will the New European Parliament be a Healthy One?
After the European elections, negotiations are currently taking place to shape the new, influential European Parliament. Although health is typical...